Maziar Mike Doustdar takes office as NVO's new CEO, bringing a proven global growth record to tackle rising obesity market ...

Novo Nordisks stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, ...

Novo Nordisk ( ($NVO) ) has shared an update. On August 8, 2025, Novo Nordisk disclosed transactions involving the sale of shares by board members ...

Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...

WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.